Ascentage Pharma To Present Data On Four Innovative Drug Candidates At ASH 2026, Including First Clinical Results For APG-5918
Ascentage Pharma Group International (NASDAQ:AAPG, HKEX: 6855))), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel, differentiated
Ascentage Pharma will show test results for four new medicines at a big doctor conference. When a drug company shares new results, pay attention to whether doctors seem excited or worried about how well the medicines work.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.